PH11611A - 1-(3-amino-2-hydroxypropoxy)isoquinoline derivatives and pharmaceutical compositions thereof - Google Patents
1-(3-amino-2-hydroxypropoxy)isoquinoline derivatives and pharmaceutical compositions thereofInfo
- Publication number
- PH11611A PH11611A PH16382A PH16382A PH11611A PH 11611 A PH11611 A PH 11611A PH 16382 A PH16382 A PH 16382A PH 16382 A PH16382 A PH 16382A PH 11611 A PH11611 A PH 11611A
- Authority
- PH
- Philippines
- Prior art keywords
- hydroxypropoxy
- amino
- pharmaceutical compositions
- isoquinoline derivatives
- isoquinoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1430773A CH581113A5 (en) | 1973-10-08 | 1973-10-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH11611A true PH11611A (en) | 1978-04-12 |
Family
ID=4399720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH16382A PH11611A (en) | 1973-10-08 | 1974-10-07 | 1-(3-amino-2-hydroxypropoxy)isoquinoline derivatives and pharmaceutical compositions thereof |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPS5082078A (en) |
| AT (1) | ATA802974A (en) |
| AU (2) | AU498889B2 (en) |
| BE (1) | BE820789A (en) |
| CA (1) | CA1021772A (en) |
| CH (1) | CH581113A5 (en) |
| DD (1) | DD114605A5 (en) |
| DE (1) | DE2447756A1 (en) |
| DK (1) | DK135766B (en) |
| ES (1) | ES430759A1 (en) |
| FI (1) | FI286374A (en) |
| FR (1) | FR2247242B1 (en) |
| GB (1) | GB1474775A (en) |
| HU (1) | HU169126B (en) |
| IL (1) | IL45797A (en) |
| NL (1) | NL7413105A (en) |
| NO (1) | NO743534L (en) |
| PH (1) | PH11611A (en) |
| SE (1) | SE7412310L (en) |
| SU (1) | SU567403A3 (en) |
| ZA (1) | ZA746409B (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI760704A (en) * | 1975-03-26 | 1976-09-27 | Sandoz Ag | |
| US4129565A (en) * | 1975-07-11 | 1978-12-12 | Nisshin Flour Milling Co., Ltd. | Isocarbostyril derivatives |
| SE7804318L (en) * | 1977-05-02 | 1978-11-03 | Merck & Co Inc | NEW NAFTYRIDINES |
| EP0711804A3 (en) | 1994-11-14 | 1999-09-22 | Ciba SC Holding AG | Latent light stabilizers |
| US6346536B1 (en) | 1997-09-03 | 2002-02-12 | Guilford Pharmaceuticals Inc. | Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same |
| US6514983B1 (en) | 1997-09-03 | 2003-02-04 | Guilford Pharmaceuticals Inc. | Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| US6426415B1 (en) | 1997-09-03 | 2002-07-30 | Guilford Pharmaceuticals Inc. | Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity |
| US6635642B1 (en) | 1997-09-03 | 2003-10-21 | Guilford Pharmaceuticals Inc. | PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same |
| US6197785B1 (en) * | 1997-09-03 | 2001-03-06 | Guilford Pharmaceuticals Inc. | Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity |
| US6291425B1 (en) | 1999-09-01 | 2001-09-18 | Guilford Pharmaceuticals Inc. | Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| US6395749B1 (en) | 1998-05-15 | 2002-05-28 | Guilford Pharmaceuticals Inc. | Carboxamide compounds, methods, and compositions for inhibiting PARP activity |
| US6387902B1 (en) | 1998-12-31 | 2002-05-14 | Guilford Pharmaceuticals, Inc. | Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP |
| AU2001264595A1 (en) | 2000-05-19 | 2001-12-03 | Guilford Pharmaceuticals Inc. | Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses |
| AU2001275085A1 (en) | 2000-06-01 | 2001-12-11 | Guilford Pharmaceuticals Inc. | Methods, compounds and compositions for treating gout |
-
1973
- 1973-10-08 CH CH1430773A patent/CH581113A5/xx not_active IP Right Cessation
-
1974
- 1974-09-30 NO NO743534A patent/NO743534L/no unknown
- 1974-09-30 SE SE7412310A patent/SE7412310L/xx unknown
- 1974-09-30 DK DK514874AA patent/DK135766B/en unknown
- 1974-10-01 FI FI2863/74A patent/FI286374A/fi unknown
- 1974-10-03 GB GB4290974A patent/GB1474775A/en not_active Expired
- 1974-10-04 NL NL7413105A patent/NL7413105A/en not_active Application Discontinuation
- 1974-10-04 DD DD181520A patent/DD114605A5/xx unknown
- 1974-10-07 IL IL45797A patent/IL45797A/en unknown
- 1974-10-07 BE BE149290A patent/BE820789A/en unknown
- 1974-10-07 JP JP49114815A patent/JPS5082078A/ja active Pending
- 1974-10-07 CA CA210,857A patent/CA1021772A/en not_active Expired
- 1974-10-07 DE DE19742447756 patent/DE2447756A1/en not_active Withdrawn
- 1974-10-07 PH PH16382A patent/PH11611A/en unknown
- 1974-10-07 ES ES430759A patent/ES430759A1/en not_active Expired
- 1974-10-07 AT AT802974A patent/ATA802974A/en not_active Application Discontinuation
- 1974-10-08 ZA ZA00746409A patent/ZA746409B/en unknown
- 1974-10-08 SU SU7402066522A patent/SU567403A3/en active
- 1974-10-08 AU AU74090/74A patent/AU498889B2/en not_active Expired
- 1974-10-08 FR FR7433761A patent/FR2247242B1/fr not_active Expired
- 1974-10-08 HU HUSA2697A patent/HU169126B/hu unknown
- 1974-10-09 AU AU74130/74A patent/AU7413074A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1474775A (en) | 1977-05-25 |
| ZA746409B (en) | 1976-05-26 |
| CH581113A5 (en) | 1976-10-29 |
| ATA802974A (en) | 1979-07-15 |
| NO743534L (en) | 1975-05-05 |
| NL7413105A (en) | 1975-04-10 |
| DE2447756A1 (en) | 1975-04-10 |
| AU7408974A (en) | 1976-04-15 |
| CA1021772A (en) | 1977-11-29 |
| IL45797A (en) | 1978-04-30 |
| DD114605A5 (en) | 1975-08-12 |
| DK135766C (en) | 1977-11-21 |
| ES430759A1 (en) | 1977-04-16 |
| AU7409074A (en) | 1976-04-15 |
| AU7413074A (en) | 1976-04-15 |
| SU567403A3 (en) | 1977-07-30 |
| IL45797A0 (en) | 1974-12-31 |
| HU169126B (en) | 1976-09-28 |
| DK514874A (en) | 1975-06-09 |
| AU498889B2 (en) | 1979-03-29 |
| SE7412310L (en) | 1975-04-09 |
| DK135766B (en) | 1977-06-20 |
| FR2247242B1 (en) | 1978-07-21 |
| BE820789A (en) | 1975-04-07 |
| FR2247242A1 (en) | 1975-05-09 |
| JPS5082078A (en) | 1975-07-03 |
| FI286374A (en) | 1975-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH10519A (en) | 4-hydroxymethyl-1-phthalazone derivatives and pharmaceutical compositions thereof | |
| PH10649A (en) | Sulphoxide derivatives and pharmaceutical compositions thereof | |
| IL44795A0 (en) | Pharmaceutical compositions containing arylthioalkanols and novel arylthioalkanols | |
| IL47625A (en) | 4-heterocyclyl-6,7-dialkoxyquin-azoline derivatives and pharmaceutical compositions containing them | |
| GB1482552A (en) | Benzomorphanes and morphinane derivatives and pharmaceutical compositions containing the same | |
| PH11611A (en) | 1-(3-amino-2-hydroxypropoxy)isoquinoline derivatives and pharmaceutical compositions thereof | |
| IL50869A0 (en) | Novel imidazole derivatives their preparation and pharmaceutical compositions containing them | |
| NZ181009A (en) | Heteroaryl derivatives and pharmaceutical compositions | |
| GB1537880A (en) | 1-triarylalkyl-4-phenyl-4-piperidine-methanols and derivatives and pharmaceutical compositions containing them | |
| PH12944A (en) | Pyrazole derivatives and their pharmaceutical composition | |
| IL45609A0 (en) | New isoquinoline derivatives,their preparation and pharmaceutical compositions containing them | |
| GB1483343A (en) | Derivatives of amitriptyline and pharmaceutical uses thereof | |
| IL48508A (en) | Pharmaceutical compositions comprising piperidylindole derivatives | |
| IL44794A0 (en) | Pharmaceutical compositions containing certain triazolyl derivatives | |
| IL50230A0 (en) | Novel imidazole derivatives their preparation and pharmaceutical compositions containing them | |
| IL43766A0 (en) | Pharmaceutical compositions containing bis-phenolalkane derivatives | |
| ZA742956B (en) | Pharmaceutical compositions containing triazolo-isoquinoline derivatives | |
| PH10643A (en) | Benzylpyrimidine derivatives and pharmaceutical compositions thereof | |
| NZ182161A (en) | Alkoxy-pyridine-carobxamide derivatives and pharmaceutical compositions | |
| PH11231A (en) | Piperidinesulfonylurea derivatives and pharmaceutical compositions containing them | |
| NZ181727A (en) | Pyrroline-2-one derivatives and pharmaceutical compositions | |
| IL47155A0 (en) | New isoquinoline derivatives,their preparation and pharmaceutical compositions containing them | |
| IL45950A (en) | 2-glycylamido-4-pyridyl-thiazole derivatives their preparation and pharmaceutical compositions containing them | |
| IE39291B1 (en) | Pharmaceutical compositions comprising an anzyme and substtrate | |
| NZ181401A (en) | 2-benzopyranone derivatives and pharmaceutical compositions |